Alliance for Cancer Gene Therapy Inc logo

Alliance for Cancer Gene Therapy Inc

Public charity · Grantmaker Stamford, CT EIN: 06-1619523 Website

Acgt supports high-risk, high-reward scientific research to develop cancer therapeutics that use the body's own cells and genes as a living medicine. By accelerating this research, acgt is helping to advance therapies that are significantly more effective and less toxic than current cancer treatments such as chemotherapy and radiation.

Alliance for Cancer Gene Therapy Inc at a glance

In short: Alliance for Cancer Gene Therapy Inc gave $2.0M across 7 grants in 2026 (avg $291K), top state Pennsylvania. Source: 2026 IRS Form 990.

Annual giving (2026)
$2,036,801
-52.9% vs 2025
Grants made (2026)
7
+40.0% vs 2025
Average grant
$290,972
-66.4% vs 2025
Median grant
$481,606
Total assets
$20,157,168
+28.1% vs 2025
Primary geography
Pennsylvania (26% of itemized 2026 grant dollars)
Latest 990 filing
Form 990, 2026 View filing

Data from IRS Form 990, 2026; updated November 2026.

How to apply to Alliance for Cancer Gene Therapy Inc

Who Alliance for Cancer Gene Therapy Inc funds

How this funder distributes its grants

Top Recipients

Top 7 recipients in 2026

University of Pennsylvania Office of Research Services: $498KUniversity of PennsylvaniaOffice of Research Services$498KMassachusetts General Hospital: $487KMassachusetts General Hospital$487KYale University: $485KYale University$485KRoswell Park Cancer Institute: $482KRoswell Park Cancer Institute$482KSt Jude Children's Research Hospital: $40KSt Jude Children's ResearchHospital$40KThe Children's Hospital of Philadelphia: $32KThe Children's Hospital ofPhiladelphia$32KFred Hutchinson Cancer Center: $13KFred Hutchinson Cancer Center$13K

The largest 2026 recipient was University of Pennsylvania Office of Research Services ($498K). Together the top 7 received $2.0M.

Grant Size Distribution

29 grants across all recorded years

14<$50K$50–100K$100–250K8$250–500K5$500K–1M2$1–5M$5M+

The most common grant size was under $50K: 14 grants of 29 (48%).

Geographic Focus

Where this funder awards grants

Grant Distribution by State

8states

Share of 2026 grant dollars across all 7 itemized grants.

Cities

PhiladelphiaNew YorkMemphisNew HavenHoustonPittsburghSeattleBostonBuffaloRedwood CitySan FranSan FransiscoSanfransicoSomerville

How Alliance for Cancer Gene Therapy Inc gives

  • Giving held roughly steady from 2023 to 2026 (+17%). Method

From the foundation's IRS Form 990 filings. Methodology.

Giving History

Giving Over Time

Total grant dollars and number of grants per year

$0$2M$4M$6M8 grants2021 6 grants2022 6 grants2023 5 grants2024 5 grants2025 7 grants2026

From 2021 to 2026, annual grant giving ranged from $1.0M (2024) to $4.3M (2025). In 2026 it made 7 grants totaling $2.0M.

Grants by year

Grant recipients and amounts by year

RecipientPurposeAmount
University of Pennsylvania Office of Research Services Philadelphia, PACancer Research$498,238
Massachusetts General Hospital Boston, MACancer Research$486,965
Yale University New Haven, CTCancer Research$484,725
Roswell Park Cancer Institute Buffalo, NYCancer Research$481,606
St Jude Children's Research Hospital Memphis, TNCancer Research$40,297
The Children's Hospital of Philadelphia Philadelphia, PACancer Research$31,825
Fred Hutchinson Cancer Center Seattle, WACancer Research$13,145
Your AI grants department

Ready to take the next step with Alliance for Cancer Gene Therapy Inc?

Fully replaces Grant database subscriptions Instrumentl · Foundation Directory · GrantStation & similar

Financial History

Multi-year comparison from IRS filings

Figures from IRS filings, by filing year
Filing yearTotal AssetsRevenueExpensesGrants paidGrantsNet Investment Income
2026$20,157,168$5,167,910$3,128,633$2,036,8017$1,340,486
2025$15,733,028$3,103,520$5,355,546$4,328,7505$917,192
2024$15,042,870$9,059,178$1,966,204$1,025,4235$294,442
2023$7,929,383$3,231,770$2,498,579$1,735,3416$435,133
2022$7,018,537$3,295,905$1,804,221$1,237,3506$607,713
2021$6,851,434$1,716,695$2,586,563$1,759,5338$206,963

About Alliance for Cancer Gene Therapy Inc

Based on IRS filings

Alliance for Cancer Gene Therapy Inc is a public charity, based in Stamford, CT. IRS filing data is available from 2021 through 2026. As of 2026, the organization holds $20.2M in total assets. In 2026, it awarded 7 grants totaling $2.0M. Net investment income was $1.3M.

Leadership & Key People

Officers and directors from IRS filings

Alliance for Cancer Gene Therapy Inc is led by Kevin Honeycutt, CEO & President since 2025 (on filings since 2021); 2 of 22 officers listed in 2026 are compensated.

Officers on the 2026 filing

  • Kevin Honeycutt

    CEO & President

    President & CEO → President, CEO & Director, 2023

    President, CEO & Director → CEO & President, 2025

    On filings since 2021

    40 hrs/week

    No compensation reported

  • Barbara Netter

    Director & Honorary Chairman

    Honorary Chairman → Director & Honorary Chairman, 2025

    On filings since 2021

    6 hrs/week

    No compensation reported

  • Alexandra Landes

    Director

    On filings since 2021

    1 hr/week

    No compensation reported

  • Chau Q. Khuong

    Director

    On filings since 2021

    1 hr/week

    No compensation reported

  • Daniel Englander

    Director

    On filings since 2021

    1 hr/week

    No compensation reported

  • John C. Sites Jr.

    Director

    On filings since 2021

    1 hr/week

    No compensation reported

  • John L. Lahey PhD

    Director

    On filings since 2021

    1 hr/week

    No compensation reported

  • Klaus R. Veitinger MD PhD

    Director

    On filings since 2021

    1 hr/week

    No compensation reported

  • Martin E. Winter

    Director

    On filings since 2021

    1 hr/week

    No compensation reported

  • Michael Gregory

    Director

    On filings since 2021

    1 hr/week

    No compensation reported

  • Peter A. Glicklich Esq.

    Director

    On filings since 2021

    1 hr/week

    No compensation reported

  • Chen Schor

    Director

    On filings since 2022

    1 hr/week

    No compensation reported

  • Maria Fardis PhD

    Director

    On filings since 2023

    1 hr/week

    No compensation reported

  • Bruce L. Levine PhD

    Director

    On filings since 2025

    1 hr/week

    No compensation reported

  • Marc Engelsgjerd MD

    Director

    On filings since 2025

    1 hr/week

    No compensation reported

  • John Neamonitis

    Director

    New on the 2026 filing

    1 hr/week

    No compensation reported

  • Jonathan Doctor

    Director

    New on the 2026 filing

    1 hr/week

    No compensation reported

  • Barbara Lavery

    Chief Program Officer

    On filings since 2021

    40 hrs/week

    $213K (2021) → $271K (2026)

  • Keri Eisenberg

    Chief Philanthropy Officer

    On filings since 2024

    40 hrs/week

    $194K (2024) → $221K (2026)

  • Christine Herman

    Vice President & Treasurer

    On filings since 2021

    2 hrs/week

    No compensation reported

  • H. William Smith

    Vice President, Legal & Secretary

    On filings since 2021

    2 hrs/week

    No compensation reported

  • Colleen Maggi

    Vice President & Treasurer

    New on the 2026 filing

    2 hrs/week

    No compensation reported

Former officers (8)
  • Former: Theresa Burgess PhD (2021–2025) — Director
  • Former: Gbola Amusa (2022–2025) — Director
  • Former: Gbola Amusamd (2023–2024) — Director
  • Former: Andrew Alisberg (2021–2022) — Director
  • Former: David M. Darst Jr. (2021–2022) — Director
  • Former: Martha Zoubek (2021–2022) — Director
  • Former: Tracy B. Holton (2021–2022) — Director
  • Former: David Englanber (2022) — Director

Data from IRS Form 990 filings, 2021–2026. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.

Compensation Overview

From 2026 IRS filing

Barbara Lavery — Chief Program Officer: $271KBarbara LaveryChief Program Officer$271KKeri Eisenberg — Chief Philanthropy Officer: $221KKeri EisenbergChief Philanthropy Officer$221K

The highest reported compensation on the 2026 filing was $271K, to Barbara Lavery (Chief Program Officer). 2 officers or directors reported compensation on that filing.

Frequently asked questions about Alliance for Cancer Gene Therapy Inc

How much does Alliance for Cancer Gene Therapy Inc give each year?

Alliance for Cancer Gene Therapy Inc gave $2.0M across 7 grants in 2026, according to its 2026 IRS Form 990. In 2025 it gave $4.3M across 5 grants.

What is Alliance for Cancer Gene Therapy Inc's typical grant size?

Alliance for Cancer Gene Therapy Inc's median grant in 2026 was $481,606, and its average grant was $290,972, across 7 grants on its 2026 IRS Form 990.

Where does Alliance for Cancer Gene Therapy Inc give grants?

Alliance for Cancer Gene Therapy Inc's top state is Pennsylvania, with 26% of the grant dollars itemized on its 2026 IRS Form 990. The next largest states were Massachusetts (24%) and Connecticut (24%). The most frequent recipient cities were Philadelphia, PA (2 grants).

Does Alliance for Cancer Gene Therapy Inc give general operating support?

Not in 2026: none of the 7 grants with a stated purpose on Alliance for Cancer Gene Therapy Inc's 2026 IRS Form 990 were described as general or operating support. Recurring purposes include "Cancer Research" (7 grants).

Who are Alliance for Cancer Gene Therapy Inc's largest grantees?

Alliance for Cancer Gene Therapy Inc's largest 2026 grantees include University of Pennsylvania Office of Research Services ($498,238), Massachusetts General Hospital ($486,965) and Yale University ($484,725), according to its 2026 IRS Form 990. Together they received 72% of its itemized 2026 grant dollars.

How large is Alliance for Cancer Gene Therapy Inc?

Alliance for Cancer Gene Therapy Inc reported $20.2M in total assets on its 2026 IRS Form 990. Its revenue that year was $5.2M.

What is Alliance for Cancer Gene Therapy Inc's EIN?

Alliance for Cancer Gene Therapy Inc's EIN (Employer Identification Number) is 06-1619523. IRS Form 990 filing data is available on this page for 2021–2026.

Data last updated November 2026. Sourced from IRS Form 990 filings.

Data update history

(7)

When this profile's IRS filing data changed on Grantable

  1. Added Form 990 for fiscal year 2026 (received by the IRS September 15, 2026)
  2. Updated Form 990 for fiscal year 2021 (received by the IRS March 3, 2022)
  3. Updated Form 990 for fiscal year 2022 (received by the IRS March 7, 2023)
  4. Updated Form 990 for fiscal year 2023 (received by the IRS January 22, 2024)
  5. Updated Form 990 for fiscal year 2024 (received by the IRS February 25, 2025)
  6. Updated Form 990 for fiscal year 2025 (received by the IRS September 11, 2025)
  7. IRS filings on file for fiscal years 2021–2025

Explore Open Grants

Browse active grant opportunities in Alliance for Cancer Gene Therapy Inc's focus areas in our free grants database

Similar Funders

Funders that support many of the same organizations

Conquer Cancer Foundation of the American Society of Clinical Oncology

Alexandria, VA

Conquer Cancer funds cancer research, professional education, and quality-care initiatives, with awards to universities, hospitals, and cancer centers in the U.S. and through international programs. Its 2024 grants ranged from $50,000 to $7.68 million, with a median of $100,000; the profile does not state whether it accepts unsolicited requests.

Medical Research

Assets

$120.7M

Grants

39

Total Given

$17.4M

The Mark Foundation for Cancer Research (US) Ltd

New York, NY

The Mark Foundation for Cancer Research funds basic, translational, and clinical cancer research, including collaborative projects and early-stage drug discovery, at institutions in the U.S. and internationally. Its 2024 grants ranged from $11,250 to $2.75 million, with a median of $500,000; ASPIRE individual applications may be considered by invitation, and no general unsolicited-request policy is stated.

Diseases, Disorders & Medical Disciplines

Assets

$105.5M

Grants

29

Total Given

$19.5M

The V Foundation

Cary, NC

The V Foundation funds high-risk, high-reward research on all types of cancer through researchers at cancer centers and other exceptional institutions in the United States and selected Canadian centers. Its grants vary by program; 2025 awards ranged from $84,000 to $3.2 million, with a median of $800,000. It does not accept unsolicited requests; selected institutions are invited to apply.

Medical Research

Assets

$145.9M

Grants

53

Total Given

$56.7M

Benaroya Research Institute at Virginia

Seattle, WA

Benaroya Research Institute funds research on immune-system health and disease, including autoimmunity, allergies, asthma, and cancer, primarily through grants to research and medical institutions. Its 2025 grants had a median of about $105,000, with awards ranging from $5,419 to $10.7 million, and went to organizations across the U.S., with the largest share of funding going to California. The profile does not state whether it accepts unsolicited requests.

Medical Research

Assets

$95.5M

Grants

66

Total Given

$27.5M

The Broad Institute Inc

Cambridge, MA

The Broad Institute funds biomedical research, especially work on disease causes, treatments, cancer, and research technologies, primarily through grants to universities, hospitals, and research centers. In 2025, grants ranged from $8,419 to $15.75 million, with a median of about $301,000; most funding went to Massachusetts organizations. The profile does not state whether it accepts unsolicited requests.

Medical Research

Assets

$3.5B

Grants

77

Total Given

$86.0M

Blood Cancer United Inc

Washington, DC

Blood Cancer United funds blood cancer research, including basic, translational, and clinical studies, along with patient and family support, quality-of-life work, and advocacy. Its 2025 grants ranged from $37,500 to $5,197,687, with a median of $370,000; funding supports work in the U.S. and internationally. The profile does not state whether it accepts unsolicited requests.

Diseases, Disorders & Medical Disciplines

Assets

$532.2M

Grants

67

Total Given

$47.7M

More similar funders

More Funders in Connecticut

The filing figures on this page are open data under CC BY 4.0. About GrantGraph Open

Figures come from Alliance for Cancer Gene Therapy Inc's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.

Alliance for Cancer Gene Therapy Inc down — hundreds of funders to go?

Want AI to do this for you?